These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 1704167
1. Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients. Frandsen F, Pless P, Mickley H, Møller M. Acta Cardiol; 1990; 45(5):351-7. PubMed ID: 1704167 [Abstract] [Full Text] [Related]
2. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395 [Abstract] [Full Text] [Related]
3. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia. Hellestrand KJ. Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396 [Abstract] [Full Text] [Related]
4. Intravenous flecainide acetate for supraventricular tachycardias. Hellestrand KJ. Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630 [Abstract] [Full Text] [Related]
5. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group. Pritchett EL, DaTorre SD, Platt ML, McCarville SE, Hougham AJ. J Am Coll Cardiol; 1991 Feb 25; 17(2):297-303. PubMed ID: 1899432 [Abstract] [Full Text] [Related]
6. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms. Katritsis D, Rowland E, O'Nunain S, Shakespeare CF, Poloniecki J, Camm AJ. Eur Heart J; 1995 Dec 25; 16(12):1930-5. PubMed ID: 8682029 [Abstract] [Full Text] [Related]
7. [Reduction of auricular fibrillation and tachycardia using intravenous flecainide]. Cohen-Solal A, Juliard JM, Jaeger P, Farinotti P, Dahan M, Charlier P, Boujon B, Aumont MC. Arch Mal Coeur Vaiss; 1987 Jul 25; 80(8):1290-6. PubMed ID: 3120666 [Abstract] [Full Text] [Related]
8. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Chimienti M, Cullen MT, Casadei G. Eur Heart J; 1995 Dec 25; 16(12):1943-51. PubMed ID: 8682031 [Abstract] [Full Text] [Related]
9. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias. Nathan AW, Camm AJ, Bexton RS, Hellestrand KJ. Clin Cardiol; 1987 May 25; 10(5):317-22. PubMed ID: 3109795 [Abstract] [Full Text] [Related]
10. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E. G Ital Cardiol; 1987 Aug 25; 17(8):690-8. PubMed ID: 3121426 [Abstract] [Full Text] [Related]
11. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia]. Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F. G Ital Cardiol; 1987 May 25; 17(5):444-9. PubMed ID: 3115857 [Abstract] [Full Text] [Related]
12. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias]. Garre L, Alvarez A, Cianciulli T, Quiroga J, Califano J, Mautner B. Arch Inst Cardiol Mex; 1989 May 25; 59(3):241-4. PubMed ID: 2506843 [Abstract] [Full Text] [Related]
13. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia. Luedtke SA, Kuhn RJ, McCaffrey FM. Ann Pharmacother; 1997 Nov 25; 31(11):1347-59. PubMed ID: 9391691 [Abstract] [Full Text] [Related]
14. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias. Nakazato Y, Nakata Y, Yasuda M, Nakazato K, Sumiyoshi M, Ogura S, Yamaguchi H. Jpn Heart J; 1997 May 25; 38(3):379-85. PubMed ID: 9290572 [Abstract] [Full Text] [Related]
15. [Efficacy of flecainide in the treatment of ventricular tachycardia in the elderly. Dynamic electrocardiographic study]. Filice A, Attanasio A, Capria A, Piccolo CG, Fabrizi E. Clin Ter; 1989 Jun 30; 129(6):459-64. PubMed ID: 2526707 [Abstract] [Full Text] [Related]
16. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia. Kuck KH, Kunze KP, Schlüter M, Duckeck W. Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166 [Abstract] [Full Text] [Related]
17. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function. Hughes MM, Trohman RG, Simmons TW, Castle LW, Wilkoff BL, Morant VA, Maloney JD. Am Heart J; 1992 Feb 20; 123(2):408-12. PubMed ID: 1736577 [Abstract] [Full Text] [Related]
18. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Boudonas G, Lefkos N, Efthymiadis AP, Styliadis IG, Tsapas G. Acta Cardiol; 1995 Feb 20; 50(2):125-34. PubMed ID: 7610735 [Abstract] [Full Text] [Related]
19. Long term evaluation of flecainide acetate in supraventricular tachyarrhythmias. Mary-Rabine L, Telerman M. Acta Cardiol; 1988 Feb 20; 43(1):37-48. PubMed ID: 3132008 [Abstract] [Full Text] [Related]
20. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Hohnloser SH, Zabel M. Am J Cardiol; 1992 Aug 20; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287 [Abstract] [Full Text] [Related] Page: [Next] [New Search]